Services-Commercial Physical & Biological Research
Headquarters
Vancouver, WA 98683
Fiscal year end
2025 (FY)
Market Data
Close
$9.10
Change
-$0.57
Change %
-5.85%
Volume
222,705
ABSI · trading date Oct 13, 2026 · previous close $9.67 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
—
Net income
-$115.18M
Total assets
$216.30M
Total liabilities
$26.85M
Stockholders' equity
$189.45M
Cash & equivalents
$20.03M
Operating income
-$120.32M
Operating cash flow
-$92.93M
Capital expenditures
$1.11M
Fiscal year 2025, via 10-K filed 2026-03-24.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$94.03M
Free cash flow margin
—
Liabilities / assets
12.4%
Equity / assets
87.6%
CapEx / revenue
—
Operating cash flow / net income
0.81×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Vancouver, WA 98683
18105 SE MILL PLAIN BLVD
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:01 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.